Subscribe: Biotechnology
http://rss.prnewswire.com/industry/bio
Preview: Biotechnology

PR Newswire: Biotechnology



Press Releases from PR Newswire about Biotechnology



Published: Thu, 19 Jan 2017 05:43:09 EST

Last Build Date: Thu, 19 Jan 2017 04:00:00 EST

 



Biosimilars Create Opportunities for Sustainable Cancer Care

Thu, 19 Jan 2017 04:00:00 EST

LUGANO, Switzerland, January 19, 2017 /PRNewswire/ -- Biosimilars create opportunities for sustainable cancer care, says ESMO in a position paper published in ESMO Open. The document outlines approval standards for biosimilars, how to safely introduce them into the clinic and...



Les biosimilaires créent des opportunités de traitement durable du cancer

Thu, 19 Jan 2017 04:00:00 EST

LUGANO, Suisse, January 19, 2017 /PRNewswire/ -- Les biosimilaires créent des opportunités de traitement durable du cancer, affirme l'ESMO dans un rapport publié dans le journal ESMO Open. Ce document met en avant les normes d'homologation des biosimilaires, explique comment les...



2017 Serbia Automated Microbiology Market: Molecular Diagnostics, Identification, Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics-- Specimen, Test, and Sales Forecasts, Competitive Strategies, Opportunities

Wed, 18 Jan 2017 18:05:00 EST

(image) LONDON, Jan. 18, 2017 /PRNewswire/ -- This new report from VPGMarketResearch.com examines current and emerging assays; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures,...



Media Files:
http://www.reportbuyer.com




BD Announces Webcast of Annual Meeting of Shareholders

Wed, 18 Jan 2017 16:30:00 EST

(image) FRANKLIN LAKES, N.J., Jan. 18, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 24, 2017, at 1 p.m. (ET). The webcast can...



Media Files:
http://www.bd.com




Synthetic Biologics Confirms Key Features of Pivotal Phase 2b/3 Trial of SYN-010 Pursuant to Consultations with FDA

Wed, 18 Jan 2017 16:09:00 EST

(image) ROCKVILLE, Md., Jan. 18, 2017 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients, today confirmed plans to initiate a Phase 2b/3 adaptive pivotal...



Media Files:
http://www.syntheticbiologics.com




New Executive Leadership at Acupath Labs

Wed, 18 Jan 2017 15:45:00 EST

(image) PLAINVIEW, N.Y., Jan. 18, 2017 /PRNewswire/ -- Acupath Laboratories, Inc., a leading provider of sub-specialized anatomic pathology services, announces the formation of an Executive Committee that will guide the company's vision and strategy in 2017 and beyond. John Cucci, a 15-year...



Media Files:
http://mma.prnewswire.com/media/458742/Acupath_Laboratories_Logo.jpg




NW Bio Presenting At Phacilitate Immunotherapy World Conference

Wed, 18 Jan 2017 15:28:00 EST

(image) BETHESDA, Md., Jan. 18, 2017 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a U.S. biotechnology company developing DCVax® personalized immune therapies for operable and inoperable solid tumor cancers, announced today that Dr. Marnix Bosch, Chief Technical...



Media Files:
http://mma.prnewswire.com/media/325355/northwest_biotherapeutics__inc__logo.jpg




Biotechnology/Pharmaceutical Services Outsourcing Market Analysis, By Service And Segment Forecasts, 2014 - 2025

Wed, 18 Jan 2017 15:17:00 EST

(image) NEW YORK, Jan. 18, 2017 /PRNewswire/ -- The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to a new report by Grand View Research, Inc. Pharmaceutical industry has been adaptive of the function of outsourcing certain clinical and...



Media Files:
http://www.reportlinker.com




Parent Project Muscular Dystrophy Awards NJIT and Talem Technologies a $600,000 Grant to Continue Exploration of an Upper Extremity Exoskeleton in Duchenne Muscular Dystrophy

Wed, 18 Jan 2017 13:26:00 EST

(image) HACKENSACK, N.J., Jan. 18, 2017 /PRNewswire-USNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today announced a $600,000 grant to be awarded to the New Jersey Institute of Technology (NJIT)...



Media Files:
http://mma.prnewswire.com/media/73833/parent_project_muscular_dystrophy_logo.jpg




Applied BioMath, LLC to present at Boston Area Group for Informatics and Modeling Meeting

Wed, 18 Jan 2017 13:24:00 EST

(image) LINCOLN, Mass., Jan. 18, 2017 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced that Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath, will present at the...



Media Files:
http://mma.prnewswire.com/media/458821/ABMTag_FullColor_Logo.jpg




Boston Biomedical to Highlight Data for Cancer Stemness Inhibitor Napabucasin in Patients with Colorectal Cancer at 2017 ASCO GI

Wed, 18 Jan 2017 12:47:00 EST

(image) CAMBRIDGE, Mass., Jan. 18, 2017 /PRNewswire/ -- Boston Biomedical, an industry leader in the development of novel compounds designed to target cancer stemness pathways, will feature data from two clinical studies for its lead investigational compound, napabucasin, at the 2017 ASCO...



Media Files:
http://mma.prnewswire.com/media/216131/boston_biomedical_logo.jpg




Dermata Therapeutics, LLC Announces Initiation of Treatment in a Phase 2 Acne Rosacea Clinical Study

Wed, 18 Jan 2017 12:00:00 EST

(image) SAN DIEGO, Jan. 18, 2017 /PRNewswire/ -- Dermata Therapeutics, LLC, a biotechnology company developing new and innovative products to treat a variety of dermatological diseases, announces dosing the first patient with its lead compound DMT210, in a Phase 2 acne rosacea study. DMT210 is a...



Media Files:
http://mma.prnewswire.com/media/367116/dermata_logo_cmyk_logo_Logo.jpg




Biotech Showcase™ 2017 brachte über 3.000 Investoren und Führungskräfte aus der Life-Sciences-Branche letzte Woche in San Francisco zusammen

Wed, 18 Jan 2017 11:56:00 EST

(image) NEW YORK und SAN FRANCISCO und CARLSBAD, Kalifornien, 18. Januar 2017 /PRNewswire/ -- Biotech Showcase™, die größte Veranstaltung des Jahres, bei der sich innovative Biotechnologie-Unternehmen den Investoren präsentieren, fand letzte Woche in San Francisco statt. Die Veranstaltung wurde...



Media Files:
http://www.ebdgroup.com




Le Biotech Showcase™ 2017 réuni plus de 3 000 investisseurs et dirigeants du secteur des sciences de la vie à San Francisco la semaine dernière

Wed, 18 Jan 2017 11:49:00 EST

(image) NEW YORK et SAN FRANCISCO et CARLSBAD, Californie, 18 janvier 2017 /PRNewswire/ -- Le Biotech Showcase™, le plus grand événement de l'année où les entreprises biotechnologiques innovantes présentent aux investisseurs, s'est conclu à San Francisco la semaine dernière. L'événement a réuni...



Media Files:
http://www.ebdgroup.com




MedNet Solutions Celebrates Unprecedented Growth In 2016

Wed, 18 Jan 2017 11:05:00 EST

(image) MINNETONKA, Minn., Jan. 18, 2017 /PRNewswire/ -- MedNet Solutions, an innovative SaaS-based eClinical technology company that supports the entire spectrum of clinical research, is proud to announce that 2016 has been another record-breaking year for the organization in terms of corporate...



Media Files:
http://mma.prnewswire.com/media/366985/mednet_solutions_large_for_poster_print_logo_Logo.jpg




In situ Hybridization Market Worth 739.9 Million USD by 2021

Wed, 18 Jan 2017 10:30:00 EST

(image) PUNE, India, January 18, 2017 /PRNewswire/ -- According to a new market research report "In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic and...



Media Files:
http://photos.prnewswire.com/prn/20160303/792302




Regenicin Reports 2016 Operating Results, Outlines Milestones for 2017

Wed, 18 Jan 2017 10:00:00 EST

(image) LITTLE FALLS, N.J., Jan. 18, 2017 /PRNewswire/ -- Regenicin, Inc. (OTC Bulletin Board: RGIN), a biotechnology company specializing in the development and commercialization of regenerative cell therapies to restore the health of damaged tissues and organs, recently reported the Company's...



Media Files:
http://www.regenicin.com




Kalorama: More IVD M&A Likely in Changing Acquisitions Landscape

Wed, 18 Jan 2017 09:28:00 EST

(image) ROCKVILLE, Md., Jan. 18, 2017 /PRNewswire/ -- In vitro diagnostic (IVD) companies were very active in 2016 with respect to mergers and acquisitions (M&A), and Kalorama Information expects that trend to continue – though the reasons for such acquisitions have been shifting. Generally,...



Media Files:
http://mma.prnewswire.com/media/451246/kalorama_information.jpg




Cancer Diagnostics Market is Predicted to Grow at a CAGR of 12% from 2016 to 2022

Wed, 18 Jan 2017 09:00:00 EST

(image) PUNE, India, Jan. 18, 2017 /PRNewswire/ -- Market Research Future published a half-cooked research report on Global Cancer Diagnostics Market. Global Cancer Diagnostics Market is expected to grow at a CAGR of 12% during the period 2016 to 2022. Market Highlights Cancer is a...



Media Files:
http://mma.prnewswire.com/media/415948/Market_Research_Future_Logo.jpg




New First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain

Wed, 18 Jan 2017 09:00:00 EST

(image) WASHINGTON, Jan. 18, 2017 /PRNewswire-USNewswire/ -- Robust competition in the private marketplace is resulting in increasingly higher rebates and discounts on medicine prices, according to a new study by the Berkeley Research Group (BRG). The study is among the first to examine the...



Media Files:
http://mma.prnewswire.com/media/458519/PRN_PHRMA_Logo.jpg